Skip to main content
VulnerabilityPublished

CVE-2026-19532: HAVELSAN Liman MYS · Path Traversal

Affects HAVELSAN Liman MYSSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 5.3 Medium : upgrade to 2.3.4-1124 when convenient.

Data as of 7 Nov 2026, 23:24 UTC

CVSS 3.1 base score
5.3Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 18% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 2.3.4-1124
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 24 Sep 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 8 Nov 2026.

What to do

Upgrade HAVELSAN Liman MYS to 2.3.4-1124.

Affected software

ProductAffectedFixed in
HAVELSAN Inc.Liman MYSAffected
  • >=2.3.2 <2.3.4-1124
Fixed in
  • 2.3.4-1124

AI-suggested

advisories for updates. If you cannot patch yet, restrict network access to the affected service and apply any recommended configuration mitigations from the vendor.

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal. This issue affects Liman MYS: from 2.3.2 before 2.3.4-1124.

References

Community reviews

Loading reviews…